SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001193125-12-045045
Filing Date
2012-02-08
Accepted
2012-02-08 07:06:26
Documents
9
Period of Report
2011-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 40-F d295204d40f.htm 40-F 77985
2 EXHIBIT 99.1 d295204dex991.htm EX-99.1 773438
3 EXHIBIT 99.2 d295204dex992.htm EX-99.2 315232
4 EXHIBIT 99.3 d295204dex993.htm EX-99.3 10113
5 EXHIBIT 99.4 d295204dex994.htm EX-99.4 9957
6 EXHIBIT 99.5 d295204dex995.htm EX-99.5 4291
7 EXHIBIT 99.6 d295204dex996.htm EX-99.6 4244
8 EXHIBIT 99.7 d295204dex997.htm EX-99.7 2005
9 GRAPHIC g295204ex99_2pg001.jpg GRAPHIC 6549
  Complete submission text file 0001193125-12-045045.txt   1207429
Mailing Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4
Business Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 40-F | Act: 34 | File No.: 001-35203 | Film No.: 12579704
SIC: 2834 Pharmaceutical Preparations